{
    "id": 24325,
    "fullName": "FGFR1 T141R",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "FGFR1 T141R lies within the extracellular domain of the Fgfr1 protein (UniProt.org). T141R has been identified in sequencing studies (PMID: 23887298, PMID: 25567908), but has not been biochemically characterized and therefore, its effect on Fgfr1 protein function is unknown (PubMed, Nov 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 7555,
                    "pubMedId": 23887298,
                    "title": "Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23887298"
                },
                {
                    "id": 10242,
                    "pubMedId": 25567908,
                    "title": "Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25567908"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2260,
        "geneSymbol": "FGFR1",
        "terms": [
            "FGFR1",
            "bFGF-R-1",
            "BFGFR",
            "CD331",
            "CEK",
            "ECCL",
            "FGFBR",
            "FGFR-1",
            "FLG",
            "FLT-2",
            "FLT2",
            "HBGFR",
            "HH2",
            "HRTFDS",
            "KAL2",
            "N-SAM",
            "OGD"
        ]
    },
    "variant": "T141R",
    "createDate": "07/14/2016",
    "updateDate": "11/24/2019",
    "referenceTranscriptCoordinates": {
        "id": 155076,
        "transcript": "NM_023110",
        "gDna": "chr8:g.38428372G>C",
        "cDna": "c.422C>G",
        "protein": "p.T141R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11544,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a pancreatic ductal adenocarcinoma patient harboring EML4-ALK along with CDKN2A deletion, FGFR1 T141R, SMAD4 Q83*, and a TP53 splice site mutation, experienced disease progression after 2 months of Xalkori (crizotinib) treatment, then received Alecensa (alectinib) and remained on treatment for at least 3 months (PMID: 28476735).",
            "molecularProfile": {
                "id": 28131,
                "profileName": "EML4 - ALK CDKN2A del FGFR1 T141R SMAD4 Q83*"
            },
            "therapy": {
                "id": 698,
                "therapyName": "Alectinib",
                "synonyms": null
            },
            "indication": {
                "id": 3498,
                "name": "pancreatic ductal adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 9613,
                    "pubMedId": 28476735,
                    "title": "Identification of Targetable ALK Rearrangements in Pancreatic Ductal Adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28476735"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11543,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a pancreatic ductal adenocarcinoma patient harboring EML4-ALK along with CDKN2A deletion, FGFR1 T141R, SMAD4 Q83*, and a TP53 splice site mutation, experienced disease progression after 2 months of Xalkori (crizotinib) treatment, then received Alecensa (alectinib) and remained on treatment for at least 3 months (PMID: 28476735).",
            "molecularProfile": {
                "id": 28131,
                "profileName": "EML4 - ALK CDKN2A del FGFR1 T141R SMAD4 Q83*"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3498,
                "name": "pancreatic ductal adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 9613,
                    "pubMedId": 28476735,
                    "title": "Identification of Targetable ALK Rearrangements in Pancreatic Ductal Adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28476735"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 25057,
            "profileName": "FGFR1 T141R",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28131,
            "profileName": "EML4 - ALK CDKN2A del FGFR1 T141R SMAD4 Q83*",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 155080,
            "transcript": "XM_006716303",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155081,
            "transcript": "XM_017013221",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155077,
            "transcript": "NM_001174065",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155074,
            "transcript": "NM_015850",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155085,
            "transcript": "XM_017013224",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155083,
            "transcript": "XM_006716307",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155076,
            "transcript": "NM_023110",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155078,
            "transcript": "XM_006716306",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155086,
            "transcript": "XM_017013225",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155079,
            "transcript": "XM_017013222",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155082,
            "transcript": "XM_017013223",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155084,
            "transcript": "XM_006716304",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155075,
            "transcript": "NM_001174063",
            "gDna": "chr8:g.38428372G>C",
            "cDna": "c.422C>G",
            "protein": "p.T141R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}